Skip to main content
SEARCH

A time for action: fighting COVID-19

The growing outbreak of COVID-19 has affected each one of us in multiple ways, our families, friends, businesses and way of life. This fast-changing situation has forced us to re-evaluate how we operate. At IQVIA, we are working on using this challenge as an opportunity to make our company more dedicated, more efficient, and more focused on serving the needs of our clients, a better company to partner with in our common mission of bringing healthcare treatments to market faster and of improving outcomes for patients. To manage through the crisis, we have established a new agile governance cadence. Our CEO Command Center meets daily at 4 p.m. EDT and maintains coordination with each of our Global Business Unit and Regional level Command Centers, as well as our Medical & Scientific Task Force, IT Task Force, HR Task Force and Finance Task Force. In this letter, we would like to update you as a leadership team on how we are managing this crisis and helping the healthcare industry respond to its challenges.

Putting safety first. Our first priority is the safety of staff and the patients, healthcare professionals, customers and suppliers we frequently interact with. To limit exposure, we have prohibited international travel, closed facilities and asked most of our staff to work remotely. We have added bandwidth and VPN capacity to our advanced infrastructure to avoid service disruptions. To date, this transition has gone smoothly. Our data production centers remain fully operational and our technology, analytics, primary market research and real-world deliveries continue in the ordinary course per existing business continuity plans.

Minimizing disruption to clinical trials. As supply chains are disrupted, as clinics and hospitals become inaccessible or as it becomes sometimes unsafe or difficult for patients to travel, we are doing everything in our power to ensure science and innovation do not stop. The situation is fluid and we have been monitoring daily, and sometimes hourly, each trial, each site, each enrolled patient, to maintain the integrity of our ongoing trials. We are coordinating closely with local health authorities and customers to deploy, when appropriate and feasible, our services and technologies to further increase remote-based CRA and centralized monitoring for trials, remote patient visits (aka virtual trials), supply logistics and other remote interactions between patients and HCPs. We are currently transitioning significant portions of trials to our Study Hub Virtual Trial execution platform, including Televisit, digital interaction and more, to enable study continuity on a global basis.

Helping organizations plan & manage for the outbreak. We are applying our people, data and technology, to bring AI and insights to help accelerate responses and planning efforts. We have provided data scientists with information and tools to understand the rapidly evolving dynamics of the outbreak to predict how things will develop. We are rolling out new remote-detailing solutions and workflows to support remote-based working. In Japan and Italy, for example, we are creating AI-powered forecasting tools that are helping predict the progression of COVID-19 — this will expand to other countries in Europe soon. In the UK, we are providing analytics and staff who are physically working side-by-side with government officials to help monitor the drug supply chain. And in the U.S., we are working with key federal agencies to provide data and insights that will help them manage capacity and demand across the health system.

Helping accelerate the development of COVID-19 treatments and vaccines. Lastly, we are joining the global response to the crisis and contributing our resources to its resolution by providing IQVIA staff, technology and expertise to support the development of new treatments. In Asia, we are providing an IQVIA team to help develop two new treatments for COVID-19 using existing HIV and flu vaccines. In the U.S., we are partnering with academic institutions to develop new lab tests to identify vaccine candidates quicker than currently available tests. And in Europe, we are collaborating with governments and the pharmaceutical industry to develop several experimental vaccine candidates using our Prime Site networks and data assets to accelerate timelines. If successful, all of these will bring much-needed treatments to patients quickly.

 


 

We would like to end this letter with a message that there is light at the end of the tunnel. This outbreak is extraordinary in terms of scale, speed, and uncertainty but there is reason to be optimistic. The Chinese National Health Commission recently reported almost no new domestic cases, approximately 60% of hospitals outside of Hubei Province are now accessible to patients, schools are slowly reopening and life beginning to normalize. Even with the recent turmoil, we are still expecting growth in the Chinese pharmaceutical market this year. Given all these signs, we are hopeful that by end of May, China will almost fully recover. You will find our latest update, insights and analysis on the situation in China by clicking HERE.

In these most unusual of circumstances, IQVIA is renewing its commitment to becoming a better partner to you, to marshal all our talents and resources at the service of the greater cause we all work for, to benefit the health and wellbeing of patients everywhere. We will continue to be here to help you accomplish this objective during and after this crisis is over.

Ari Bousbib
Chairman & CEO

 

More information can be found in the IQVIA candidate resource centre, which can be found by clicking HERE
List #1

IQVIA Related insights

Group of three young coworkers working together in a sunny office.Man typing on computer keyboard. Woman pointing hand to desktop screen. Horizontal image, blurred background
What does a market access manager do and why should you become one?

Teaser

General

Content Type

Article

Published

17/07/2024

Summary

Market access is all about preparing a drug for market entry, and as such it’s a vitally important part of the drug development process and wider pharmaceutical industry. While for pharmaceutical an

Teaser

Market access is all about preparing a drug for market entry, and as such it’s a vitally important part of the drug development process and wider pharmaceutical industry.

Read more
tablet PC and medical equipments, medical technology concept
How to turn a medical science liaison job into a career

Teaser

Medical Affairs & Services

Content Type

Article

Published

04/07/2024

Summary

Becoming a Medical Science Liaison is a popular career choice for many Doctoral-level candidates seeking a meaningful role within the pharmaceutical industry where they can communicate scientifically

Teaser

We look at the possible medical science liaison career paths that could be available to you.

Read more
Tracey Smith

by

Tracey Smith

Tracey Smith

by

Tracey Smith

A person in a medical jacket holding a box of pills typing on a laptop
Clinical Pharmacist Interview Tips: Securing Your Next Opportunity

Teaser

Patient Centric Services (PCS)

Content Type

Article

Published

04/07/2024

Summary

The clinical pharmacy industry is booming. Since the pandemic, the general public has become more aware of how pharmacists play a vital role in healthcare. Naturally, the market for these roles is al

Teaser

IQVIA has compiled some top Clinical Pharmacist Interview Tips.

Read more
Ruth Lynn

by

Ruth Lynn

Ruth Lynn

by

Ruth Lynn

Amir, clinical pharmacist at IQVIA
Clinical Pharmacist duties - a day in the life

Teaser

Patient Centric Services (PCS)

Content Type

Article

Published

01/07/2024

Summary

If you’ve been doing your research into your next clinical pharmacy-based career, you might find yourself thinking “What are the daily activities of a Clinical Pharmacist?”.  To answer that question

Teaser

We caught up with Amir Khosravi-Nik, Senior Clinical Pharmacist at IQVIA.

Read more
Catherine Scott

by

Catherine Scott

Catherine Scott

by

Catherine Scott

Kareem, clinical pharmacist at IQVIA interface
IQVIA Interface - Kareem’s Clinical Pharmacist career story

Teaser

Clinical Operations

Content Type

Article

Published

28/06/2024

Summary

Kareem Mohamed joined IQVIA Interface in 2023 as a Clinical Pharmacist after having previously worked as a Primary Care Network (PCN) Pharmacist.  Our Clinical Pharmacists play a huge part in any h

Teaser

Kareem Mohamed joined IQVIA Interface in 2023 as a Clinical Pharmacist.

Read more
Ruth Lynn

by

Ruth Lynn

Ruth Lynn

by

Ruth Lynn

hands holding a red heart against a blue backdrop
5 ways you can celebrate World Well-being Week this year

Teaser

General

Content Type

Article

Published

29/05/2024

Summary

World Well-being Week 2024 is just around the corner. As an organisation with a passion for building a healthier world, our mission is not just confined to healthcare and medical sales, it also exten

Teaser

World Well-being Week 2024 is near, here are 5 ways you can celebrate.

Read more
Ruth Lynn

by

Ruth Lynn

Ruth Lynn

by

Ruth Lynn

Tips on how to keep your work life and home life separate

Teaser

General

Content Type

Article

Published

30/04/2024

Summary

Whether you work remotely, with a hybrid model, or are a careerist who can’t help but mentally take your work home with you when you leave the office, it’s undeniable that the lines between work and

Teaser

Explore learnable skills, tricks, and techniques that can empower you in your lifestyle

Read more
man in white lab coat holding glasses and talking to a man and woman
Why should you work in medical sales?

Teaser

Medical Sales & Services

Content Type

Article

Published

19/03/2024

Summary

Are you wondering if medical sales is a good career? All over the world, the medical and pharmaceutical sectors are booming, and nowhere more so than in the UK. With a thriving ecosystem of research

Teaser

All over the world, the medical and pharmaceutical sectors are booming, and nowhere more so than in the UK.

Read more
Two women on an interview
Navigating Career Growth and Flexibility at IQVIA: a Q&A with Lucy

Teaser

General

Content Type

Article

Published

05/02/2024

Summary

Lucy Manning sits in our clinical trials team, but that’s not where her career started at IQVIA. It all began at the back end of 2022 when Lucy took on a fixed-term contract as a Project Support Coo

Teaser

Lucy took on a fixed-term contract as a Project Support Coordinator. . But that did not signal the end of her time working with us.

Read more
doctor and medical sales representative shake hands
The Ultimate A-Z of Becoming a Medical Sales Rep

Teaser

Sales

Content Type

Article

Published

02/02/2024

Summary

Does the idea of being a medical sales rep excite you? This crucial position lets you make connections with companies and practitioners in the medical field. It’s also a growing and dynamic industry.

Teaser

This crucial position lets you make connections with companies and practitioners in the medical field.

Read more
female phlebotomist taking a blood sample from a male
How to become a phlebotomist

Teaser

Patient Centric Services (PCS)

Content Type

Article

Published

04/01/2024

Summary

Are you ready to step into a career that's both rewarding and accessible? Becoming a phlebotomist could be your ticket into the thriving world of healthcare. It's not just about drawing blood; it's ab

Teaser

Ready to discover how you could take the leap into this exciting field?

Read more
Young sad female nurse, doctor, carer looking through window, wearing face mask gazing at sun
Marissa's inspiring journey as a nurse advisor at IQVIA

Teaser

Medical

Content Type

Article

Published

20/11/2023

Summary

In the tapestry of healthcare, where expertise meets innovation, individuals like Marissa, a Senior Nurse Advisor at IQVIA, play a pivotal role.  Marissa has not only learned from challenges but has e

Teaser

If you consider the path of a Nurse Advisor, Marissa's story is a testament to the opportunities and fulfilment that await at IQVIA.

Read more